10.0007.15% ( -0.770 )
已收盤: 11月17日 16:00:00 (美東)股東
全部股東
股東類型
- 公眾及其他36.72%
- 創投/私募25.25%
- 上市公司22.96%
- 機構投資者13.15%
- 個人與內幕人士1.92%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Eli Lilly and Company | 20.36% | 548.09 萬 | -- | +548.09 萬 | 13/10/2026 |
SV Health Investors, LLC | 14.77% | 397.53 萬 | -- | +397.53 萬 | 13/10/2026 |
Johnson & Johnson Innovation - JJDC, Inc. | 5.48% | 147.53 萬 | -- | +147.53 萬 | 13/10/2026 |
Alexandria Venture Investments, LLC | 5.00% | 134.65 萬 | -- | +134.65 萬 | 13/10/2026 |
Pfizer Venture Investments LLC | 4.70% | 126.51 萬 | -- | +126.51 萬 | |
Janus Henderson Group Ltd. | 4.67% | 125.61 萬 | -- | +125.61 萬 | |
Polaris Growth Management, L.L.C. | 3.78% | 101.88 萬 | -- | +101.88 萬 | |
Pfizer Inc. | 2.60% | 70.00 萬 | -- | +70.00 萬 | |
Carol GallagherLead Independent Director | 0.93% | 25.15 萬 | -- | +25.15 萬 | |
Laura BernerChief Operating Officer | 0.63% | 16.86 萬 | -- | +16.86 萬 | |
Joel MarcusIndependent Director | 0.16% | 4.19 萬 | -- | +4.19 萬 | 13/10/2026 |
K. HirthIndependent Director | 0.14% | 3.82 萬 | -- | +3.82 萬 | |
Ali ZarrinChief Scientific Officer & Executive Director of Drug Discovery | 0.07% | 1.81 萬 | -- | +1.81 萬 | |
Transce3nd, LLC | <0.01% | 100.00 | -- | +100.00 | 30/09/2026 |
Marion ErwinChairman & CEO | 0.00% | 0.00 | -- | +0 | |
Travis CoyIndependent Director | 0.00% | 0.00 | -- | +0 |
